Loading, please wait ...


News Analytics

5204602349 c87b204860 b jpg?t3RDhbNCPVY1nBuHcXXQaS PTYKSyw6B.
Having originally proposed an accelerated approval to the FDA, Avrobio has now said it “can no longer pursue an accelerated approval pathway for AVR-RD-01 with the FAB-GT trial as currently designed.” The plan now is to run a new registration trial, as was discussed as a possibility in Avrobio’s original proposal to the FDA.

Subject Matter

  • Business, economics, society 57.41%
    • Society and people 100.00%
  • Healthcare 42.59%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions